These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30452612)

  • 1. Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?
    Ridker PM; Koenig W; Kastelein JJ; Mach F; Lüscher TF
    Eur Heart J; 2018 Dec; 39(46):4109-4111. PubMed ID: 30452612
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a).
    Grützmacher P; Öhm B; Szymczak S; Dorbath C; Brzoska M; Kleinert C
    Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):22-26. PubMed ID: 28233269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JUPITER study highlights C-reactive protein as a cardiac risk factor.
    Cardiovasc J Afr; 2009; 20(2):146. PubMed ID: 19421655
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid Lowering Is Beneficial for Secondary Prevention but Not Primary Prevention in Patients 75 Years and Older.
    Ebell MH
    Am Fam Physician; 2021 Jun; 103(11):695-696. PubMed ID: 34060787
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholesterol and inflammatory risk: Insights from secondary and primary prevention.
    Stock JK
    Atherosclerosis; 2019 Jan; 280():192-193. PubMed ID: 30458965
    [No Abstract]   [Full Text] [Related]  

  • 6. New Approaches for the Prevention and Treatment of Cardiovascular Disease: Focus on Lipoproteins and Inflammation.
    Hussain A; Ballantyne CM
    Annu Rev Med; 2021 Jan; 72():431-446. PubMed ID: 33217249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editor's presentation.
    Piepoli MF
    Eur J Prev Cardiol; 2017 Jul; 24(10):1011-1013. PubMed ID: 28618853
    [No Abstract]   [Full Text] [Related]  

  • 8. Omega-3 polyunsaturated fatty acid in primary and secondary cardiovascular disease prevention.
    Chalupka S
    AAOHN J; 2009 Nov; 57(11):480. PubMed ID: 19968213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary Prevention of Cardiovascular Diseases and Application of Technology for Early Diagnosis.
    Karunathilake SP; Ganegoda GU
    Biomed Res Int; 2018; 2018():5767864. PubMed ID: 29854766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin for Primary and Secondary Prevention of Cardiovascular Disease.
    Godley RW; Hernandez-Vila E
    Tex Heart Inst J; 2016 Aug; 43(4):318-9. PubMed ID: 27547141
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins: have we found the Holy Grail?
    Jeger R; Dieterle T
    Swiss Med Wkly; 2012; 142():w13515. PubMed ID: 22315166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. I've heard that statins can can help lower C-reactive proteins (CRP) levels. I'm 65, but I don't take a statin because my cholesterol is low. Should I be concerned about CRP? I have a family history of heart disease.
    Heart Advis; 2011 Feb; 14(2):8. PubMed ID: 22957365
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between triglycerides and cardiovascular events in primary populations: a meta-regression analysis and synthesis of evidence.
    Stauffer ME; Weisenfluh L; Morrison A
    Vasc Health Risk Manag; 2013; 9():671-80. PubMed ID: 24204156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-lowering therapy with statins for the primary and secondary prevention of cardiovascular disease.
    Lardizabal JA; Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):87-103. PubMed ID: 21257102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for cardiovascular disease prevention.
    Gupta R; Deedwania P
    Cardiol Clin; 2011 Feb; 29(1):15-34. PubMed ID: 21257098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociating HDL cholesterol from cardiovascular risk.
    Hausenloy DJ; Opie L; Yellon DM
    Lancet; 2010 Jul; 376(9738):305-6. PubMed ID: 20655104
    [No Abstract]   [Full Text] [Related]  

  • 17. An Update on Aspirin for Cardioprevention: Implications for Patient Care.
    Cannon CP
    J Fam Pract; 2021; 70(1 suppl [i]):S1-S10. PubMed ID: 33752228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The primary role of cardiologists in cardiovascular prevention].
    Onder L; Nicolosi GL
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):131S-132S. PubMed ID: 20879500
    [No Abstract]   [Full Text] [Related]  

  • 19. Accreditation of clinical centres providing primary prevention, secondary prevention and rehabilitation, and sports cardiology: A step towards optimizing quality.
    Janssen A; Wagenaar KP; Dendale P; Grobbee DE
    Eur J Prev Cardiol; 2019 Nov; 26(16):1775-1777. PubMed ID: 31362532
    [No Abstract]   [Full Text] [Related]  

  • 20. Implications of Premature Coronary Artery Calcification in Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease.
    Khetarpal SA; Honigberg MC; Natarajan P
    JAMA Cardiol; 2021 Nov; 6(11):1233-1234. PubMed ID: 34495295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.